We hypothesized that the ACE2 inhibitor MLN-4760 deteriorates NO- and H2S-mediated relaxations and increases vascular contractility, which may result in further exacerbation of pre-existing hypertension in SHRs. Here, ACE2 is linked to hypertensive disorder.